JNK and p۳۸ gene and protein expression during liver ischemia-reperfusion in a rat model treated with silibinin
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 149
This Paper With 9 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-25-11_012
تاریخ نمایه سازی: 30 مهر 1401
Abstract:
Objective(s): Signal transduction of mitogen-activated protein kinases (MAPKs) is activated during ischemia. In this study, c-Jun N-terminal Kinase (JNK) and p۳۸ MAPK (p۳۸) gene and protein expression were evaluated as two members of the MAPK family during liver ischemia-reperfusion in rats.Materials and Methods: Thirty-two male Wistar rats were divided into four groups of eight: Vehicle, ischemia-reperfusion (IR), ischemia-reperfusion+silibinin (IR+SILI), and SILI. The IR and IR+SILI groups differed from the other two groups in that they underwent one hour of ischemia followed by three hr of reperfusion. The Vehicle and IR groups received normal saline while the SILI and IR+SILI groups were treated with silibinin (۵۰ mg/kg). At the end of the reperfusion time, blood and ischemic liver tissue were collected for further experiments.Results: The expression of JNK and p۳۸ gene, the amount of serum hepatic injury indices, and malondialdehyde (MDA) in the IR group increased significantly compared with the vehicle group. The JNK and p۳۸ gene expression decreased significantly in the IR + SILI group compared with the IR group. Glutathione peroxidase (GPx) and total antioxidant capacity (TAC) levels decreased in the IR group while increasing in the IR+SILI group. Histological examination showed that silibinin significantly reduced the severity of hepatocyte degradation. Western blot results were completely consistent with real-time PCR results.Conclusion: The possible pathways of the protective effect of silibinin against hepatic ischemia damages is to reduce the expression of the p۳۸ and JNK gene and protein.
Keywords:
Authors
Nastaran Aamani
Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Abouzar Bagheri
Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Neda Masoumi Qajari
Genetic Biology, Islamic Azad University of Tonekabon, Tonekabon, Iran
Majid Malekzadeh Shafaroodi
Department of Anatomy and Biology, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Abbas Khonakdar-Tarsi
Department of Clinical Biochemistry and Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :